FAKTOR-OPTIONSSCHEIN - VIATRIS Stock

Certificat

DE000MG31A27

Market Closed - Börse Stuttgart 05:54:47 2024-05-17 am EDT
9.59 EUR -6.53% Intraday chart for FAKTOR-OPTIONSSCHEIN - VIATRIS
Current month+14.03%
Date Price Change
24-05-17 9.59 -6.53%
24-05-16 10.26 +11.04%
24-05-15 9.24 -5.04%
24-05-14 9.73 +7.87%
24-05-13 9.02 -7.01%

Delayed Quote Börse Stuttgart

Last update May 17, 2024 at 05:54 am EDT

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying VIATRIS INC.
Issuer Morgan Stanley
WKN MG31A2
ISINDE000MG31A27
Date issued 2024-04-25
Strike 12.86 $
Maturity Unlimited
Parity 0.16 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 10.4
Lowest since issue 6.88
Spread 0.09
Spread %0.83%

Company Profile

Viatris Inc. is a global healthcare company. The Company's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. Its Developed Markets segment comprises its operations primarily in North America and Europe. The Greater China segment includes its operations in China, Taiwan and Hong Kong. The JANZ segment consists of its operations in Japan, Australia and New Zealand. The Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies, including in Asia, Africa, Eastern Europe, Latin America and the Middle East, as well as the Company’s ARV franchise. Its portfolio comprises more than 1,400 approved molecules across a range of key therapeutic areas, including key brands and generics, including complex products. It operates around 40 manufacturing sites worldwide that produce oral solid doses, injectables, complex dosage forms and active pharmaceutical ingredients.
Sector
-
More about the company

Ratings for Viatris Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Viatris Inc.

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
10
Last Close Price
10.98 USD
Average target price
12.33 USD
Spread / Average Target
+12.32%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW